Literature DB >> 9167119

The limitations of clinical trials for prevention of IDDM.

J L Mahon1, J Dupre.   

Abstract

Entities:  

Mesh：

Year:  1997        PMID： 9167119     DOI： 10.2337/diacare.20.6.1027

Source DB:  PubMed          Journal:  Diabetes Care        ISSN： 0149-5992            Impact factor:   19.112


× No keyword cloud information.
  5 in total

1.  Combined positivity for HLA DQ2/DQ8 and IA-2 antibodies defines population at high risk of developing type 1 diabetes.

Authors:  K Decochez; I Truyen; B van der Auwera; I Weets; E Vandemeulebroucke; I H de Leeuw; B Keymeulen; C Mathieu; R Rottiers; D G Pipeleers; F K Gorus
Journal:  Diabetologia       Date:  2005-03-09       Impact factor: 10.122

2.  Identification of prediabetes in first-degree relatives at intermediate risk of type I diabetes.

Authors:  I Truyen; J De Grijse; I Weets; L Kaufman; L Pipeleers; N Nanos; K Decochez; R Hilbrands; J-M Kaufman; B Keymeulen; C Mathieu; L Van Gaal; D G Pipeleers; F K Gorus
Journal:  Clin Exp Immunol       Date:  2007-05-22       Impact factor: 4.330

3.  Screening for insulinoma antigen 2 and zinc transporter 8 autoantibodies: a cost-effective and age-independent strategy to identify rapid progressors to clinical onset among relatives of type 1 diabetic patients.

Authors:  F K Gorus; E V Balti; I Vermeulen; S Demeester; A Van Dalem; O Costa; H Dorchy; S Tenoutasse; T Mouraux; C De Block; P Gillard; K Decochez; J M Wenzlau; J C Hutton; D G Pipeleers; I Weets
Journal:  Clin Exp Immunol       Date:  2013-01       Impact factor: 4.330

4.  HLA-A*24 is an independent predictor of 5-year progression to diabetes in autoantibody-positive first-degree relatives of type 1 diabetic patients.

Authors:  Eric Mbunwe; Bart J Van der Auwera; Ilse Vermeulen; Simke Demeester; Annelien Van Dalem; Eric V Balti; Sara Van Aken; Luc Derdelinckx; Harry Dorchy; Jean De Schepper; Chris van Schravendijk; Janet M Wenzlau; John C Hutton; Daniël Pipeleers; Ilse Weets; Frans K Gorus
Journal:  Diabetes       Date:  2012-11-16       Impact factor: 9.461

5.  Prediction of Impending Type 1 Diabetes through Automated Dual-Label Measurement of Proinsulin:C-Peptide Ratio.

Authors:  Annelien Van Dalem; Simke Demeester; Eric V Balti; Bart Keymeulen; Pieter Gillard; Bruno Lapauw; Christophe De Block; Pascale Abrams; Eric Weber; Ilse Vermeulen; Pieter De Pauw; Daniël Pipeleers; Ilse Weets; Frans K Gorus
Journal:  PLoS One       Date:  2016-12-01       Impact factor: 3.240
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.